dc.contributor.author | Williams, JL | en_US |
dc.contributor.author | Smith, CJ | en_US |
dc.contributor.author | Mastroianni, G | en_US |
dc.contributor.author | Stewart, M | en_US |
dc.contributor.author | Cutillas, P | en_US |
dc.contributor.author | Tinker, A | en_US |
dc.contributor.author | Metherell, L | en_US |
dc.date.accessioned | 2024-04-29T09:47:55Z | |
dc.date.issued | 2023-08-04 | en_US |
dc.identifier.issn | 0009-7330 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/96506 | |
dc.publisher | Wolters Kluwer | en_US |
dc.relation.ispartof | Circulation Research | en_US |
dc.subject | Cardiovascular | en_US |
dc.subject | Genetics | en_US |
dc.subject | Heart Disease | en_US |
dc.subject | Rare Diseases | en_US |
dc.subject | 2 Aetiology | en_US |
dc.subject | 2.1 Biological and endogenous factors | en_US |
dc.subject | Cardiovascular | en_US |
dc.title | Abstract P2043: Loss Of Full-length Mylk3 Causes Dilated Cardiomyopathy Via A Myl2-independent Mechanism | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1161/res.133.suppl_1.p2043 | en_US |
pubs.issue | Suppl_1 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 133 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | The role of MYLK3 in cardiac signalling and development::British Heart Foundation | en_US |
qmul.funder | The role of MYLK3 in cardiac signalling and development::British Heart Foundation | en_US |